| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.1M | +4.5% | +9.6% |
| Cost of Revenue | $3.6M | +1.3% | +61.3% |
| Gross Profit | $6.4M | +6.4% | -7.2% |
| R&D Expense | $1.5M | -23.7% | +22.3% |
| SG&A Expense | $3.2M | -6.7% | -2.3% |
| Operating Income | -$3.5M | +23.4% | -267.3% |
| Pre-tax Income | -$3.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.6M | -11.8% | +89.6% |
| Short-term Investments | $0 | -100.0% | — |
| Accounts Receivable | $5.3M | -25.0% | +41.9% |
| Inventory | $3.6M | -11.6% | +7.7% |
| Current Assets | $22.9M | -18.2% | +56.1% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.4M | — | — |
| Capital Expenditures | $3.0M | — | — |
| Investing Cash Flow | -$2.5M | — | — |
| Financing Cash Flow | $3.9M | — | — |
| Free Cash Flow | -$16.4M | — | — |
| +21.3% |
| -300.1% |
| Income Tax | $136K | -8.5% | +59.8% |
| Net Income | -$3.7M | +20.9% | -279.0% |
| EPS (Basic) | -$0.09 | +18.2% | -200.0% |
| EPS (Diluted) | -$0.09 | +18.2% | -200.0% |
| $34.1M |
| -11.9% |
| +108.9% |
| Current Liabilities | $9.2M | -21.7% | +31.6% |
| Long-term Debt | $2.4M | +81.3% | — |
| Total Liabilities | $19.5M | -7.6% | +177.1% |
| Stockholders' Equity | $14.6M | -17.0% | +57.4% |